Skip to content
Dose Brief
Menu
No. 2 on the board · Grade A−Partner

Eden review

A polished, high-disclosure program with strong nationwide coverage — you pay more, but you know exactly what you're paying for.

Visit Eden Partner — we may earn a commission, at no cost to you. It never changes the score.
Semaglutide
$239/mo
Tirzepatide
$349/mo
Coverage
All 50 states
Brand-name
Compounded only
On the trackerStableprice stablePremium line steady; high supply-chain disclosure keeps our confidence high.

The scorecard

Eden scored on our six Brief Score factors. See the methodology.

Price Stability89/100
Supply Reliability92/100
Transparency93/100
Access Breadth90/100
Clinical Oversight92/100
Track Record89/100

What we like

  • High verification confidence — clear supply-chain and clinician disclosure
  • Nationwide availability
  • Both molecules offered at a stable published rate

The caveats

  • Premium pricing vs the cheapest tiers
  • Compounded only — no brand-name access

The brief

Best for: Readers who prioritize a vetted, high-transparency desk over the lowest sticker price. A polished, high-disclosure program with strong nationwide coverage — you pay more, but you know exactly what you're paying for.

Ranked #2 of 9 providers we reviewed — see our #1 pick, CoreAge Rx, for comparison.

Compare with other providers

All 8 other providers we've reviewed, in our overall ranking order.

Pricing, states and verification reflect Eden's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on Eden's site. Not medical advice; see our disclosure.

← Back to all rankings